公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2016 | Should pertuzumab be used as part of neoadjuvant treatment prior to the release of the APHINITY trial results? | WEI-WU CHEN ; CHING-HUNG LIN ; CHIUN-SHENG HUANG | Translational Cancer Research | 1 | 1 | |
2022 | A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma | WEI-WU CHEN ; CHIA-LANG HSU ; RUEY-LONG HONG ; JEN-CHIEH LEE ; Chang, Koping; CHIH-WEI YU ; Chen, San-Chi; JHE-CYUAN GUO ; Chen, Mei-Lu; Hsu, Meng-Chi; Kung, Ting-Fang; ANN-LII CHENG ; Yen, Chueh-Chuan | Clinical cancer research : an official journal of the American Association for Cancer Research | 6 | 6 | |
2022 | Soft tissue sarcoma incidences and clinical characteristics are significantly different in France and Taiwan | WEI-WU CHEN ; Chiang, Ruru Chun-Ju; Le Cesne, Alex; Hsieh, Yu-Chun; Italiano, Antoine; Yang, Ya-Wen; Penel, Nicolas; WEN-CHUNG LEE ; Bompas, Emmanuelle; Valentin, Thibaud; Anract, Philippe; Firmin, Nelly; Duffaud, Florence; ANN-LII CHENG ; Ducimetiere, Francoise; KIN-WEI CHAN ; Blay, Jean-Yves | Cancer | 3 | 2 | |
2022 | Spectrum of cancer patients receiving renal biopsy | FAN-CHI CHANG ; WEI-WU CHEN ; TAO-MIN HUANG ; WEI-CHOU LIN ; Liu, Jia-Sin; WEN-CHIH CHIANG ; YUNG-MING CHEN ; CHIUN HSU ; KUN-HUEI YEH ; TZONG-SHINN CHU | Journal of the Formosan Medical Association = Taiwan yi zhi | 1 | 0 | |
2017 | Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review | Prawira A.; Oosting S.F.; WEI-WU CHEN ; Delos Santos K.A.; Saluja R.; Wang L.; Siu L.L.; Chan K.K.W.; Hansen A.R. | British Journal of Cancer | 66 | 58 | |
2021 | Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature | Frezza A.M.; Ravi V.; Lo Vullo S.; Vincenzi B.; Tolomeo F.; WEI-WU CHEN ; Teterycz P.; Baldi G.G.; Italiano A.; Penel N.; Brunello A.; Duffaud F.; Hindi N.; Iwata S.; Smrke A.; Fedenko A.; Gelderblom H.; Van Der Graaf W.; Vozy A.; Connolly E.; Grassi M.; Benjamin R.S.; Broto J.-M.; Grignani G.; Jones R.L.; Kawai A.; Tysarowski A.; Mariani L.; Casali P.G.; Stacchiotti S. | Cancer Medicine | 21 | 18 | |
2020 | Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival | WEI-WU CHEN ; I-SHIOW JAN ; DWANG-YING CHANG ; CHING-HUNG LIN ; I-CHUN CHEN ; Chen H.-M.; ANN-LII CHENG ; YEN-SHEN LU | Journal of Neuro-Oncology | 17 | 13 | |
2016 | Tailor the adjuvant hormonal manipulation for premenopausal breast cancer patients | WEI-WU CHEN ; CHING-HUNG LIN ; YEN-SHEN LU | Translational Cancer Research | 0 | 0 | |
2020 | Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study | Gounder M.; Sch?ffski P.; Jones R.L.; Agulnik M.; Cote G.M.; Villalobos V.M.; Attia S.; Chugh R.; WEI-WU CHEN ; Jahan T.; Loggers E.T.; Gupta A.; Italiano A.; Demetri G.D.; Ratan R.; Davis L.E.; Mir O.; Dileo P.; Van Tine B.A.; Pressey J.G.; Lingaraj T.; Rajarethinam A.; Sierra L.; Agarwal S.; Stacchiotti S. | The Lancet Oncology | 196 | 149 | |
2020 | Tertiary Lymphoid Structures and B cells: Clinical impact and therapeutic modulation in cancer | Saut?s-Fridman C.; Verneau J.; Sun C.-M.; Moreira M.; WEI-WU CHEN ; Meylan M.; Petitprez F.; Fridman W.H. | Seminars in Immunology | 47 | 36 | |
2015 | TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays | CHING-HUNG LIN ; Chen I.-C.; CHIUN-SHENG HUANG ; Hu F.-C.; WEN-HUNG KUO ; KUAN-TING KUO ; Wang C.-C.; Wu P.-F.; DWANG-YING CHANG ; Wang M.-Y.; Chang C.-H.; WEI-WU CHEN ; YEN-SHEN LU ; ANN-LII CHENG | Scientific Reports | 10 | 11 | |
2023 | Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma | HUANG-CHUN LIEN ; Hsu, Chia-Lang; YEN-SHEN LU ; WEI-WU CHEN ; I-CHUN CHEN ; Li, Yu-Chia; CHIUN-SHENG HUANG ; ANN-LII CHENG ; CHING-HUNG LIN | Breast cancer research : BCR | 0 | 0 | |
2021 | The treatment landscape of advanced angiosarcoma in Asia-A multi-national collaboration from the Asian Sarcoma Consortium | WEI-WU CHEN ; Pang A.; Puhaindran M.E.; Maw M.M.; Loong H.H.; Sriuranpong V.; Chang C.-C.; Mingmalairak S.; Hirose T.; Endo M.; Kawai A.; Farid M.; Tan S.H.; Goh W.L.; Quek R.; Chan J.C.H.; Leung A.K.C.; Ngan R.K.C. | Cancer Science | 8 | | |
2022 | Tumor Immune Microenvironment of Soft Tissue Sarcoma | WEI-WU CHEN ; SHENG-FANG SU ; Tseng, William W. | Cancer Metastasis Through the Lymphovascular System | 1 | 0 | |
2021 | Tumor-infiltrating lymphocyte abundance and programmed death-ligand 1 expression in metaplastic breast carcinoma: implications for distinct immune microenvironments in different metaplastic components | HUANG-CHUN LIEN ; Lee Y.-H.; I-CHUN CHEN ; CHING-HUNG LIN ; WEI-WU CHEN ; Lu Y.-T.; YEN-SHEN LU | Virchows Archiv | 15 | 13 | |
2020 | When molecular-targeted agents meet immunotherapy: The opportunities for soft tissue sarcoma | Wainsztein V.E.; WEI-WU CHEN | Journal of Immunotherapy and Precision Oncology | 2 | 0 | |
2024 | Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial | WEI-WU CHEN ; Dai, Ming-Shen; Tseng, Ling-Ming; Chen, Shin-Cheh; Chao, Tsu-Yi; Chao, Ta-Chung; Chang, Yuan-Ching; Chiu, Chang-Fang; Liu, Chien-Ting; Lin, Ching-Hung; Liu, Chun-Yu; YA-FANG CHEN ; DWANG-YING CHANG ; Yu, Jyh-Cherng; Rau, Kun-Ming; Hsieh, Yao-Yu; Shen, Shih-Che; Huang, Shu-Min; ANN-LII CHENG ; YEN-SHEN LU | JAMA oncology | 0 | | |
2022 | XPF activates break-induced telomere synthesis | Guh, Chia-Yu; Shen, Hong-Jhih; Chen, Liv WeiChien; Chiu, Pei-Chen; Liao, I-Hsin; Lo, Chen-Chia; Chen, Yunfei; Hsieh, Yu-Hung; Chang, Ting-Chia; Yen, Chien-Ping; Chen, Yi-Yun; WEI-WU CHEN ; Chen, Liuh-Yow; Wu, Ching-Shyi; Egly, Jean-Marc; HSUEH-PING CHU | Nature communications | 8 | 7 | |